Graham Capital Management, L.P. Deciphera Pharmaceuticals, Inc. Transaction History

Graham Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $205,149 - $246,550	15,448 New	15,448 $217,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $563,401 - $920,647	45,509 New	45,509 $841,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $401,949 - $650,023	-58,508 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $450,511 - $2.17 Million	58,508 New	58,508 $571,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.